Symbol="CERS"
AssetType="Common Stock"
Name="Cerus Corporation"
Description="Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in Concord, California."
CIK="1020214"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="SURGICAL & MEDICAL INSTRUMENTS & APPARATUS"
Address="1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="308744000"
EBITDA="-38424000"
PERatio="None"
PEGRatio="0"
BookValue="0.281"
DividendPerShare="0"
DividendYield="0"
EPS="-0.26"
RevenuePerShareTTM="0.86"
ProfitMargin="-0.332"
OperatingMarginTTM="-0.268"
ReturnOnAssetsTTM="-0.124"
ReturnOnEquityTTM="-0.796"
RevenueTTM="153432000"
GrossProfitTTM="87094000"
DilutedEPSTTM="-0.26"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.052"
AnalystTargetPrice="5.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4.742"
PriceToBookRatio="9.56"
EVToRevenue="4.324"
EVToEBITDA="-23.21"
Beta="1.056"
num_52WeekHigh="4.73"
num_52WeekLow="1.7"
num_50DayMovingAverage="2.445"
num_200DayMovingAverage="2.89"
SharesOutstanding="180552000"
DividendDate="None"
ExDividendDate="None"
symbol="CERS"
open="1.72"
high="1.83"
low="1.70"
price="1.71"
volume="1260662.00"
latest_trading_day="2023-08-18"
previous_close="1.74"
change="-0.03"
change_percent="-1.7241%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="79"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="21"
Volume_recent_avg="1238323"
Change_recent_avg="-0.01"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.7"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="21"
Aroon_momentum_negative="79"
image_negative_thumbnail_id_1="170"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0006.jpeg"
image_negative_thumbnail_id_2="1089"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0122.jpeg"
image_neutral_thumbnail_id_1="572"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0027.jpeg"
image_neutral_thumbnail_id_2="585"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_positive_thumbnail_id_1="632"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0076.jpeg"
image_positive_thumbnail_id_2="1002"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0164.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
